Correction to: Nature https://doi.org/10.1038/s41586-021-03990-6 Published online 30 June 2021
In this version of this Article originally published, there were errors in Fig. 2 and in the references list. Specifically, in the Fig. 2c colour key, the middle cyan key now reading “JNJ-A07, 10 mg per kg, b.i.d” was missing the number of units, “10,” in the originally published version. Further, refs. 27 and 28 were swapped in the references list; their correct order appears below. The original Article has been corrected online.
Low, J. G., Ooi, E. E. & Vasudevan, S. G. Current status of dengue therapeutic research and development. J. Infect. Dis. 215, S96–S102 (2017).
Unlocking the Potential of Preventive Therapies for Malaria. World Health Organization, https://www.who.int/malaria/media/preventive-therapies/en/ (7 April 2017).
About this article
Cite this article
Kaptein, S.J.F., Goethals, O., Kiemel, D. et al. Publisher Correction: A pan-serotype dengue virus inhibitor targeting the NS3–NS4B interaction. Nature 599, E2 (2021). https://doi.org/10.1038/s41586-021-04123-9